Intrathecal therapy vs. standard care for severe cancer pain
Part of Pain clinical trials.
This trial compares a treatment that delivers pain medicine directly to the spinal cord (intrathecal therapy) with usual pain control. It is for people with severe cancer pain that is not helped by oral or intravenous opioids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with any type of cancer that causes severe pain.
- You have been using strong painkillers (opioids) for at least 4 weeks but they are no longer working well or cause side effects that stop you from taking more.
- Your pain is still at least 5 on a 0–10 scale when at rest, despite trying more than one opioid rotation.
- You can receive the spinal-cord pump (intrathecal drug delivery device) and follow all study visits.
- Your life expectancy is 6 months or more.
- You are not pregnant or planning pregnancy within 1 month after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new type of spinal cord stimulator (SCS) can reduce pain caused by chemotherapy. If you have lasting nerve pain after cancer treatment and standard pain medications haven't helped, this device might offer relief.
This study tests a new way to manage severe pain linked to pancreatic cancer when standard pain medicine isn't working or causes side effects. It aims to see if this treatment can safely reduce pain and improve quality of life.
This trial tests if adding lidocaine and ketamine to your current pain medicines can better control severe cancer-related pain that opioids alone haven't helped.
This trial compares two ways to manage pain after surgery for testicular cancer: a single injection of morphine into the spine (intrathecal morphine) vs. methadone given through an IV during surgery. The goal is to see which provides better pain relief and fewer side effects.
This Phase 1 trial tests a new drug related to capsaicin (resiniferatoxin) to reduce severe nerve pain from advanced cancer. It is given through a small catheter near the spinal fluid space and is meant for people whose pain medicines and other options have not worked well enough.
This study compares two ways to manage pain after laparoscopic colon surgery: one uses a morphine injection near the spinal cord, the other uses an epidural catheter for ongoing pain relief. The goal is to find which approach works better with fewer side effects.
Hear when a new Intrathecal Drug Delivery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.